Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing medicines for serious infectious diseases and cancer. Its portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers (TCEs) across validated targets in solid tumor indications. It also has a portfolio of preclinical programs across a range of infectious diseases and oncologic malignancies. Its key product candidates include Elebsiran (VIR-2218); Tobevibart (VIR-3434); VIR-5818; VIR-5525, and VIR-5500. These molecules leverage the PRO-XTEN masking technology with TCEs targeting CD3 on T-cells and HER2, PSMA and EGFR, respectively, on tumor cells. Elebsiran is an investigational hepatitis B virus (HBV)-targeted small interfering RNA that reduces hepatitis B surface antigen (HBsAg). Tobevibart is an investigational neutralizing monoclonal antibody that has been engineered for immune engagement and targets a conserved region on the HBsAg.
Back to dashboard
Company Information
About this company
Key people
Jeffrey S. Hatfield
Independent Chairman of the Board
Marianne De Backer
President, Chief Executive Officer, Director
Brent Sabatini
Interim Principal Financial Officer, Senior Vice President, Chief Accounting Officer
Vanina de Verneuil
Executive Vice President, General Counsel, Corporate Secretary
Timothy P. Coughlin
Director
Norbert W. Bischofberger
Independent Director
Ramy Farid
Independent Director
Robert J. More
Independent Director
Click to see more
Key facts
- Shares in issue169.22m
- EPICVIR
- ISINUS92764N1028
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$1.83bn
- Employees367
- ExchangeNASDAQ
- IndexS&P 600 Small Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.